Immuneering names Andrew Gengos as chief financial officer
Go back to Immuneering names Andrew Gengos as chief financial officer| ImaRx Therapeutics, Inc. (NASDAQ: IMRX) | Delayed: 4.54 +0.10 (2.25%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.44 | 52 Week High | $0.04 | |||
| Open | $4.38 | 52 Week Low | $0.00 | |||
| Day High | $4.67 | P/E | N/A | |||
| Day Low | $4.38 | EPS | $-0.09 | |||
| Volume | 935,614 | |||||
